Smooth Drug Development May 2024 News Release

We are working on the following new projects:

• A phase 3 clinical trial of Nimesulide Gel 2% was awarded to SDD.
• We are launching start-up activities for full-service bioequivalence study with Cabotegravir.
• Smooth received agreements for medical writing services with Rebamipid + Sodium Alginate and with Ursodeoxycholic acid+berberberine, tablets.

We are happy to reach the following milestones in our projects:

• An enrollment was finished in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
• An enrollment was finished in a phase III trial with Esomeprazole.